Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial

Table 2

Clinical primary outcomes.

Primary outcome measures	Study group ()	Control group ()	Relative risk (95% CI)	value
28-day mortality (all causes)	20/40 (50%)	33/42 (78.58%)	0.636 (0.449–0.901)	0.007
28-day mortality (hospitalization)	7/40 (17.5%)	23/42 (54.76%)	0.320 (0.154–0.661)	<0.001